Penumbra Inc

Penumbra, Inc. develops, manufactures, and markets medical technologies for challenging conditions like ischemic stroke, venous thromboembolism (including pulmonary embolism), and acute limb ischemia. The company specializes in thrombectomy, focusing on removing blood clots from the body using computer assisted vacuum thrombectomy (CAVT). Penumbra's product portfolio also includes technologies for embolization and access. Founded in 2004, Penumbra has introduced products into the thrombectomy market since 2007, the access market since 2008, the embolization market since 2011, and the neurosurgical market since 2014. The company's research and development activities support regulatory submissions and demonstrate product effectiveness. Penumbra aims to provide cost-effective products to specialist physicians and other healthcare providers to improve clinical and health outcomes. When a new generation product is introduced, sales of the older product typically decline.